Home » Topics » Disease categories and therapies » Infection

Infection
RSS

SPA-S-843 superior to amphotericin B in several in vitro assays

Feb. 22, 2000

Guanacastepene, a novel antibiotic from a fungal source active against MRSA and VREF

Feb. 22, 2000

Clinical development of new class of antibiotics begins at AVI BioPharma

Feb. 22, 2000

Hong Kong researchers present new antimalarial artemisinin derivatives

Feb. 21, 2000

Preliminary results of phase III Nyotran clinical trial

Feb. 21, 2000

European patent describes preparation and activity of new erythromycin antibiotics

Feb. 18, 2000

Sankyo discovers new antibacterials produced by Streptomyces

Feb. 17, 2000

First clinical trial of MBI-853NL begins

Feb. 17, 2000

Recently approved AmBisome label includes claim of superior safety compared to Abelcet

Feb. 16, 2000

New artemisinin derivatives from Hong Kong active against sensitive and resistant malarial strains

Feb. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...